CD24 and neoplasm: We cultured these tumor cells and found that most (> 90%) of the cells maintained their CD24+CD29high feature and less than 2% of the cells were CD24+CD29low, whereas, as a control, about half of the p18−/− tumor cells were CD24+CD29low (Additional file 2: Figure S2D).